Cargando…

Statin-associated muscle symptoms (SAMS) in primary prevention for cardiovascular disease in older adults: a protocol for a systematic review and meta-analysis of randomised controlled trials

INTRODUCTION: Although statins are commonly used for prevention of cardiovascular disease, there is limited evidence about statin-related adverse effects in older people. Statin-related adverse events (AEs), especially the statin-associated muscle symptoms (SAMS), are the most common reasons for the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhou, Zhen, Albarqouni, Loai, Breslin, Monique, Curtis, Andrea J, Nelson, Mark
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2017
Materias:	Cardiovascular Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5623566/ https://www.ncbi.nlm.nih.gov/pubmed/28963307 http://dx.doi.org/10.1136/bmjopen-2017-017587

Ejemplares similares

Statins for extension of disability-free survival and primary prevention of cardiovascular events among older people: protocol for a randomised controlled trial in primary care (STAREE trial)
por: Zoungas, Sophia, et al.
Publicado: (2023)

Tackling statin intolerance with n-of-1 trials (TaSINI) in primary care: protocol for a feasibility randomised trial to increase statin adherence
por: Tudor, Kate, et al.
Publicado: (2020)

Intensity of statin therapy and muscle symptoms: a network meta-analysis of 153 000 patients
por: Davis, John W, et al.
Publicado: (2021)

Study protocol for statin web-based investigation of side effects (StatinWISE): a series of randomised controlled N-of-1 trials comparing atorvastatin and placebo in UK primary care
por: Herrett, Emily, et al.
Publicado: (2017)

Wildfire smoke exposure and cardiovascular disease—should statins be recommended to prevent cardiovascular events?
por: Vuorio, Alpo, et al.
Publicado: (2023)

Statins for the primary prevention of cardiovascular disease: an overview of systematic reviews
por: Byrne, Paula, et al.
Publicado: (2019)

The effect of statins on average survival in randomised trials, an analysis of end point postponement
por: Kristensen, Malene Lopez, et al.
Publicado: (2015)

Combined antihypertensive and statin therapy for the prevention of cardiovascular events in patients with hypertension without complications: protocol for a systematic review and meta-analysis
por: Wang, Ying, et al.
Publicado: (2018)

Legacy effects of statins on cardiovascular and all-cause mortality: a meta-analysis
por: Nayak, Agnish, et al.
Publicado: (2018)

Effectiveness of blood pressure-lowering drug treatment by levels of absolute risk: post hoc analysis of the Australian National Blood Pressure Study
por: Ho, Chau Le Bao, et al.
Publicado: (2018)

Text messages for primary prevention of cardiovascular disease: the TextMe2 randomised controlled trial protocol
por: Klimis, Harry, et al.
Publicado: (2020)

Hydrophilic or Lipophilic Statins?
por: Climent, Elisenda, et al.
Publicado: (2021)

Cerebrovascular Disease and Statins
por: Beltrán Romero, Luis M., et al.
Publicado: (2021)

Skeletal Muscle Microvascular Dysfunction Manifests Early in Diabetic Cardiomyopathy
por: Loai, Sadi, et al.
Publicado: (2021)

Cross-sectional analysis of the prevalence and predictors of statin utilisation in Ireland with a focus on primary prevention of cardiovascular disease
por: Byrne, Paula, et al.
Publicado: (2018)

Commentary: Beyond 10-year risk: A cost-effectiveness analysis of statins for the primary prevention of cardiovascular disease
por: Shah, Aditya, et al.
Publicado: (2022)

U-Shaped Relationship of Non-HDL Cholesterol With All-Cause and Cardiovascular Mortality in Men Without Statin Therapy
por: Zeng, Rui-Xiang, et al.
Publicado: (2022)

Multifactorial intervention to prevent cardiovascular disease in patients with early rheumatoid arthritis: protocol for a multicentre randomised controlled trial
por: Svensson, Annemarie Lyng, et al.
Publicado: (2016)

Statin therapy in multimorbid older patients with polypharmacy- a cross-sectional analysis of the Swiss OPERAM trial population
por: Adam, Luise, et al.
Publicado: (2023)

Statins in Non-alcoholic Steatohepatitis
por: Torres-Peña, Jose D., et al.
Publicado: (2021)

Coronary Artery Calcification Under Statin Therapy and Its Effect on Cardiovascular Outcomes: A Systematic Review and Meta-Analysis
por: Lai, Runmin, et al.
Publicado: (2020)

Achievement of low-density lipoprotein cholesterol targets in Chinese patients with atherosclerotic cardiovascular disease after receiving statins and ezetimibe
por: Cheng, Yinchu, et al.
Publicado: (2022)

Assessing potential population impact of statin treatment for primary prevention of atherosclerotic cardiovascular diseases in the USA: population-based modelling study
por: Yang, Quanhe, et al.
Publicado: (2017)

Increased residual cardiovascular risk in U.S. veterans with moderately-elevated baseline triglycerides and well-controlled LDL-C levels on statins
por: Leatherman, Sarah, et al.
Publicado: (2022)

Undertreatment or Overtreatment With Statins: Where Are We?
por: García-Fernández-Bravo, Irene, et al.
Publicado: (2022)

Improving early diagnosis of cardiovascular disease in patients with type 2 diabetes and COPD: protocol of the RED-CVD cluster randomised diagnostic trial
por: Groenewegen, Amy, et al.
Publicado: (2021)

Examining anti-inflammatory therapies in the prevention of cardiovascular events: protocol for a systematic review and network meta-analysis of randomised controlled trials
por: Boczar, Kevin Emery, et al.
Publicado: (2022)

Effects of a laboratory-based aerobic exercise intervention on brain volume and cardiovascular health markers: protocol for a randomised clinical trial
por: Molina Hidalgo, Cristina, et al.
Publicado: (2023)

Protocol for the HAPPY Hearts study: cardiovascular screening for the early detection of future adverse cardiovascular outcomes in middle-aged and older women: a prospective, observational cohort study
por: Boreskie, Kevin F, et al.
Publicado: (2017)

Initiation rates of statin therapy for the primary prevention of cardiovascular disease: an assessment of differences between countries of the UK and between regions within England
por: O'Keeffe, Aidan G, et al.
Publicado: (2015)

While you’re waiting, a waiting room-based, cardiovascular disease-focused educational program: protocol for a randomised controlled trial
por: Mcintyre, Daniel, et al.
Publicado: (2020)

Microvascular Dysfunction in Skeletal Muscle Precedes Myocardial Vascular Changes in Diabetic Cardiomyopathy: Sex-Dependent Differences
por: Loai, Sadi, et al.
Publicado: (2022)

Statin adherence and risk of acute cardiovascular events among women: a cohort study accounting for time-dependent confounding affected by previous adherence
por: Lavikainen, Piia, et al.
Publicado: (2016)

Increase in the oxidised low-density lipoprotein level by smoking and the possible inhibitory effect of statin therapy in patients with cardiovascular disease: a retrospective study
por: Ogawa, Kazuo, et al.
Publicado: (2015)

Establishing plausibility of cardiovascular adverse effects of immunotherapies using Mendelian randomisation
por: Le, Nhu Ngoc, et al.
Publicado: (2023)

Rationale, design and study protocol of the randomised controlled trial: Diabetes Interventional Assessment of Slimming or Training tO Lessen Inconspicuous Cardiovascular Dysfunction (the DIASTOLIC study)
por: Gulsin, Gaurav Singh, et al.
Publicado: (2019)

Effect of spironolactone on cardiovascular morbidity and mortality in patients with hypertension and glucose metabolism disorders (ESCAM): a study protocol for a pragmatic randomised controlled trial
por: Li, Nanfang, et al.
Publicado: (2020)

Randomised clinical trial using Coronary Artery Calcium Scoring in Australian Women with Novel Cardiovascular Risk Factors (CAC-WOMEN Trial): study protocol
por: Marschner, Simone, et al.
Publicado: (2022)

Protocol for the WARM Hearts study: examining cardiovascular disease risk in middle-aged and older women - a prospective, observational cohort study
por: Rose, Alexandra V, et al.
Publicado: (2021)

Statin use in adults at high risk of cardiovascular disease mortality: cross-sectional analysis of baseline data from The Irish Longitudinal Study on Ageing (TILDA)
por: Murphy, Catriona, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_eulj43cucatjun52jcrp48kqrk